HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Emil Valizada Selected Research
Emil Valizada Research Topics
Disease
1
Seizures (Absence Seizure)
01/2023
1
Status Epilepticus (Complex Partial Status Epilepticus)
01/2023
1
Thymoma (Thymic Carcinoma)
01/2023
1
Epilepsia Partialis Continua
01/2023
1
Herpes Simplex Encephalitis (Herpes Encephalitis)
01/2023
1
Encephalitis (Encephalitis, Rasmussen)
01/2023
1
Inflammation (Inflammations)
01/2023
1
Multiple Sclerosis
01/2023
1
Neoplasms (Cancer)
01/2023
1
Demyelinating Diseases (Demyelinating Disease)
01/2019
1
Metachromatic Leukodystrophy (Sulfatide Lipidosis)
01/2019
1
Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked)
01/2019
1
Mycoses (Diseases, Fungus)
01/2018
1
Chronic Granulomatous Disease
01/2018
Drug/Important Bio-Agent (IBA)
1
Rituximab (Mabthera)
FDA Link
01/2023
1
Natalizumab (Tysabri)
FDA Link
01/2023
1
Alemtuzumab (Campath)
FDA Link
01/2023
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2023
1
Cyclosporine (Ciclosporin)
FDA Link
Generic
01/2023
1
Autoantibodies
IBA
01/2023
1
gamma-Aminobutyric Acid (GABA)
IBA
01/2023
1
Interferons
IBA
01/2023
1
GABA-A Receptors (GABA(A) Receptor)
IBA
01/2023
1
Lipids
IBA
01/2019
1
Superoxides (Superoxide)
IBA
01/2018
Therapy/Procedure
1
Therapeutics
01/2023
1
Aftercare (After-Treatment)
01/2023
1
General Anesthesia
01/2023